The global soft tissue repair market size was valued at USD 14.65 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. The market for soft tissue repair is expanding due to the increasing occurrence of sports injuries and the growing elderly population who are more susceptible to such injuries. Additionally, advancements in minimally invasive surgical techniques and innovative products such as bioengineered scaffolds and regenerative medicine improve treatment outcomes and stimulate market growth. The rise in obesity rates, which is linked to a higher incidence of soft tissue injuries, and the increasing demand for cosmetic surgeries are also driving market growth. Moreover, the emphasis on enhancing patient outcomes and increased healthcare spending is leading to greater adoption of advanced soft tissue repair solution
Increasing research and development activities, especially by established companies, are driving the market's growth. The rise in product launches and the high adoption of advanced technology are expected to propel market growth further. Additionally, well-structured healthcare systems in regions such as North America facilitate the early adoption of new technology and products.
The increasing popularity of minimally invasive surgical methods, which offer shorter recovery times and less postoperative pain, is accelerating the market growth. The growing preference for minimally invasive surgeries is driven by advancements in medical technology, including enhanced imaging systems and specialized surgical instruments, which enable surgeons to perform complex repairs with greater accuracy. This trend is expected to continue driving the growth of the soft tissue repair market, as more patients and healthcare providers recognize the benefits of these innovative approaches.
The tissue matrix segment accounted for a revenue share of 52.1% in 2023. The demand for effective soft tissue repair solutions is increasing due to sports-related injuries, accidents, and conditions such as hernias and orthopedic injuries, which are more prevalent in an aging population and rising obesity rates. Leading market players have introduced innovative tissue matrix products through technological advancements and extensive research and development efforts. Adopting minimally invasive surgical techniques has also contributed to the growth of the tissue matrix segment by offering improved patient outcomes and faster recovery times. These factors collectively drive the tissue matrix segment's robust growth and revenue share in the soft tissue repair market.
The laparoscopic instruments segment is expected to grow at a CAGR of 6.4% over the forecast period. This growth can be attributed to the increasing adoption of minimally invasive surgical procedures, which offer benefits such as reduced recovery times and lower risk of complications compared to traditional open surgeries. Laparoscopic instruments, including dissectors, graspers, scissors, and needle holders, play a crucial role in these procedures by allowing surgeons to perform precise and delicate operations through small incisions. The rising prevalence of conditions requiring soft tissue repair, such as hernias and sports-related injuries, further drives the demand for these instruments.
The orthopedic segment accounted for the largest revenue share in 2023. This dominance can be attributed to the high incidence of musculoskeletal injuries, which often require surgical intervention for effective treatment. Conditions such as rotator cuff tears, anterior cruciate ligament (ACL) injuries, and other sports-related injuries are prevalent, driving the demand for orthopedic soft tissue repair devices.
The orthopedic segment is projected to grow at the fastest CAGR over the forecast period. Advancements in surgical techniques and the development of innovative products, such as bio-integrative solutions and minimally invasive devices, have further bolstered the segment’s growth. The increasing geriatric population, which is more susceptible to orthopedic conditions, also plays a significant role in the segment’s revenue share.
The cardiovascular segment is anticipated to grow in the coming years. A growing number of cardiovascular repair surgeries and increasing adoption of patches/mesh in cardiovascular surgeries is expected to boost demand for soft tissue repair products.
The breast reconstruction segment is anticipated to grow at a CAGR of 7.1% over the forecast period. With the growing number of women suffering from breast cancer, the number of breast reconstruction surgeries is projected to grow significantly during the forecast period, which in turn is expected to boost demand for soft tissue repair products used for breast reconstruction surgeries and in turn promote growth.
The hospitals segment accounted for the largest revenue share in 2023. The high volume of surgical procedures are performed in hospital settings, where advanced medical infrastructure and specialized healthcare professionals are readily available. Hospitals are often the primary choice for patients requiring complex soft tissue repair surgeries, such as those involving hernias, ligament tears, and other musculoskeletal injuries. The availability of state-of-the-art equipment and comprehensive post-operative care in hospitals further enhances patient outcomes, making them a preferred option for both patients and healthcare providers.
The outpatient facilities segment is expected to grow at a significant CAGR over the forecast period. The increasing preference for minimally invasive procedures drives the growth of the outpatient facilities. These procedures can be performed in outpatient settings and offer patients the convenience of shorter hospital stays and quicker recovery times. Outpatient facilities are equipped with advanced medical technologies and staffed by skilled healthcare professionals, enabling them to efficiently handle a wide range of soft tissue repair procedures. Additionally, the cost-effectiveness of treatments in outpatient settings compared to traditional hospital stays makes them an attractive option for patients and healthcare providers.
North America soft tissue repair market dominated the global market in 2023. The region has a high incidence of sports-related injuries, which necessitates advanced soft tissue repair solutions. Additionally, the aging population in North America is growing, leading to an increased prevalence of conditions that require soft tissue repair, such as hernias and rotator cuff injuries.
The U.S. soft tissue repair market dominated the North American market with a revenue share of 89.3% in 2023. Continuous advancements in medical technology, including the development of innovative surgical techniques have significantly enhanced the effectiveness and outcomes of soft tissue repair procedures.
Europe's soft tissues repair market was identified as a lucrative region in 2023. The rising prevalence of chronic illnesses and the increasing geriatric population have significantly boosted the demand for soft tissue repair procedures. Additionally, the region has witnessed a surge in sports and recreational activities, leading to a higher incidence of sports-related injuries that require advanced repair solutions.
The Asia Pacific soft tissue repair market is anticipated to grow at the fastest CAGR over the forecast period. This growth is driven by several factors, including the rising incidence of chronic illnesses and an aging population.
Some key companies in the soft tissue repair market include Stryker Corporation; Smith & Nephew Plc.; Becton, Dickinson and Company; Arthrex, Inc.; Medtronic Plc.; Johnson & Johnson and others. To position themselves more competitively in the market, key players actively engage in various partnerships, mergers, and acquisitions. This strategic approach aims to expand their device range and extend their presence into new business territories. Furthermore, these companies employ tactics such as product differentiation and bundling strategies to secure a larger portion of the market share.
The following are the leading companies in the soft tissue repair market. These companies collectively hold the largest market share and dictate industry trends.
Report Attribute |
Details |
Market size value in 2024 |
USD 15.65 billion |
Revenue forecast in 2030 |
USD 22.89 billion |
Growth Rate |
CAGR of 6.5% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, Application, End Use, and Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, Kuwait and UAE |
Key companies profiled |
Becton, Dickinson and Company; Stryker Corporation; Smith & Nephew Plc. Arthrex, Inc.; Medtronic Plc.; Johnson & Johnson; Zimmer Biomet; Baxter International, Inc.; Integra LifeSciencesArtivion, Inc. (CryoLife, Inc.); ACell Inc.; Tissue Regenix Group Plc |
Customization scope |
Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global soft tissue repair market report based on product, application, end use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Tissue Matrix
Synthetic Mesh
Biological Mesh
Allograft
Xenograft
Tissue Fixation Products
Suture Anchors
Interference Screws
Other Fixation Devices
Laparoscopic Instruments
Application Outlook (Revenue, USD Million, 2018 - 2030)
Hernia Repair
Cardiovascular
Skin Repair
Orthopedic
Dental
Breast Reconstruction Repair
Vaginal Sling Procedures
Other applications
End Use Insights (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
Italy
France
Spain
Norway
Sweden
Denmark
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East Africa
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."